OBJECTIVES: In a well-defined sample, we sought to determine which clinical variables, some of potential nosological relevance, influence subsequent course following prospectively observed initial episodes of hypomania or mania (H/M). METHODS: We identified 108 individuals in the National Institute of Mental Health Collaborative Depression Study diagnosed with unipolar major depression at intake who subsequently developed H/M. We assessed time to repeat H/M based on whether one had been started on an antidepressant or electroconvulsive therapy within eight weeks of developing H/M, had longer episodes, or had a family history of bipolar disorder. RESULTS: Modeling age of onset, treatment-associated H/M, family history of bipolar disorder, duration of index H/M episode, and psychosis in Cox regression analysis, family history of bipolar disorder (n=21) was strongly associated with repeat episodes of H/M [hazard ratio (HR)=2.01, 95% confidence interval (CI): 1.06-3.83, p=0.03]. Those with treatment-associated episodes (n=12) were less likely to experience subsequent episodes of H/M, although this was not significant in the multivariate model (HR=0.25, 95% CI: 0.06-1.05, p=0.06). These individuals also had a later age of onset for affective illness and were more likely to be depressed. Duration of illness with a temporal resolution of one week, psychosis, and age of onset were not associated with time to repeat H/M episode. CONCLUSIONS: A family history of bipolar disorder influences the course of illness, even after an initial H/M episode. In this select sample, treatment-associated H/M did not appear to convey the same risk for a course of illness characterized by recurrent H/M episodes.
OBJECTIVES: In a well-defined sample, we sought to determine which clinical variables, some of potential nosological relevance, influence subsequent course following prospectively observed initial episodes of hypomania or mania (H/M). METHODS: We identified 108 individuals in the National Institute of Mental Health Collaborative Depression Study diagnosed with unipolar major depression at intake who subsequently developed H/M. We assessed time to repeat H/M based on whether one had been started on an antidepressant or electroconvulsive therapy within eight weeks of developing H/M, had longer episodes, or had a family history of bipolar disorder. RESULTS: Modeling age of onset, treatment-associated H/M, family history of bipolar disorder, duration of index H/M episode, and psychosis in Cox regression analysis, family history of bipolar disorder (n=21) was strongly associated with repeat episodes of H/M [hazard ratio (HR)=2.01, 95% confidence interval (CI): 1.06-3.83, p=0.03]. Those with treatment-associated episodes (n=12) were less likely to experience subsequent episodes of H/M, although this was not significant in the multivariate model (HR=0.25, 95% CI: 0.06-1.05, p=0.06). These individuals also had a later age of onset for affective illness and were more likely to be depressed. Duration of illness with a temporal resolution of one week, psychosis, and age of onset were not associated with time to repeat H/M episode. CONCLUSIONS: A family history of bipolar disorder influences the course of illness, even after an initial H/M episode. In this select sample, treatment-associated H/M did not appear to convey the same risk for a course of illness characterized by recurrent H/M episodes.
Authors: A Rousseva; C Henry; D van den Bulke; G Fournier; J-L Laplanche; M Leboyer; F Bellivier; J-M Aubry; P Baud; M Boucherie; C Buresi; F Ferrero; A Malafosse Journal: Pharmacogenomics J Date: 2003 Impact factor: 3.550
Authors: Jane E Persons; William H Coryell; David A Solomon; Martin B Keller; Jean Endicott; Jess G Fiedorowicz Journal: Bipolar Disord Date: 2017-08-23 Impact factor: 6.744
Authors: Ahmed Akhter; Jess G Fiedorowicz; Tao Zhang; James B Potash; Joseph Cavanaugh; David A Solomon; William H Coryell Journal: Bipolar Disord Date: 2013-04-27 Impact factor: 6.744
Authors: Bryan S Cobb; William H Coryell; Joseph Cavanaugh; Martin Keller; David A Solomon; Jean Endicott; James B Potash; Jess G Fiedorowicz Journal: Compr Psychiatry Date: 2014-08-04 Impact factor: 3.735
Authors: Boris Birmaher; Mary Kay Gill; David A Axelson; Benjamin I Goldstein; Tina R Goldstein; Haifeng Yu; Fangzi Liao; Satish Iyengar; Rasim S Diler; Michael Strober; Heather Hower; Shirley Yen; Jeffrey Hunt; John A Merranko; Neal D Ryan; Martin B Keller Journal: Am J Psychiatry Date: 2014-09 Impact factor: 18.112
Authors: Boris Birmaher; John A Merranko; Mary Kay Gill; Danella Hafeman; Tina Goldstein; Benjamin Goldstein; Heather Hower; Michael Strober; David Axelson; Neal Ryan; Shirley Yen; Rasim Diler; Satish Iyengar; Michael W Kattan; Lauren Weinstock; Martin Keller Journal: J Am Acad Child Adolesc Psychiatry Date: 2020-01-21 Impact factor: 8.829
Authors: David A Solomon; Jess G Fiedorowicz; Andrew C Leon; William Coryell; Jean Endicott; Chunshan Li; Robert J Boland; Martin B Keller Journal: J Clin Psychiatry Date: 2013-03 Impact factor: 4.384